Astonea Labs Limited (BOM:544409)
266.35
+5.15 (1.97%)
At close: Jul 7, 2026
Astonea Labs Revenue
In the fiscal year ending March 31, 2026, Astonea Labs had annual revenue of 1.48B INR with 51.34% growth. Astonea Labs had revenue of 812.93M in the half year ending March 31, 2026.
Revenue
1.48B
Revenue Growth
+51.34%
P/S Ratio
1.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.80B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.48B | 500.66M | 51.34% |
| Mar 31, 2025 | 975.18M | 173.27M | 21.61% |
| Mar 31, 2024 | 801.91M | 131.40M | 19.60% |
| Mar 31, 2023 | 670.51M | 369.94M | 123.08% |
| Mar 31, 2022 | 300.57M | 7.30M | 2.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Albert David | 3.34B |
| Medico Remedies | 2.06B |
| Ambalal Sarabhai Enterprises | 2.02B |
| Medicamen Biotech | 2.01B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.97B |
| Gennex Laboratories | 1.73B |
| Kerala Ayurveda | 1.31B |